Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;69(7):1815-1825.
doi: 10.1111/jgs.17108. Epub 2021 Mar 18.

Clinical impact of compound sarcopenia in hospitalized older adult patients with heart failure

Amy Attaway  1 , Annette Bellar  2 , Faty Dieye  3 , Douglas Wajda  3   4 , Nicole Welch  3   2 , Srinivasan Dasarathy  3   2
Affiliations

Clinical impact of compound sarcopenia in hospitalized older adult patients with heart failure

Amy Attaway et al. J Am Geriatr Soc. 2021 Jul.

Abstract

Objectives: Skeletal muscle loss or sarcopenia is a frequent complication in heart failure (HF) and contributes to adverse clinical outcomes. We evaluated if age (primary) and chronic disease (secondary) related sarcopenia, that we refer to as compound sarcopenia, impacts clinical outcomes in hospitalized patients with HF.

Design: Cross-sectional study using hospitalized patient data.

Setting: Data from the Agency for Healthcare Research and Quality through the Healthcare Cost and Utilization Project (HCUP).

Participants: Hospitalized adult patients with a primary or secondary diagnosis of HF (n = 64,476) and a concurrent random 2% sample of general medical population (GMP; n = 322,217) stratified by age (<50 years of age [y], 51-65y, >65y) from the Nationwide Inpatient Sample (NIS) database (years 2010-2014).

Measurements: In-hospital mortality, length of stay (LoS), cost of hospitalization per admission (CoH), comorbidities and discharge disposition, with and without muscle loss phenotype, were analyzed. Muscle loss phenotype was defined using a comprehensive code set from international classification of diseases-9 (ICD-9).

Results: Muscle loss phenotype was observed in 8673 (13.5%) patients with HF compared to 5213 (1.6%) GMP across all age strata. In patients with HF, muscle loss phenotype was associated with higher mortality, LoS, and CoH. Patients with HF (>65y) and muscle loss phenotype had higher mortality (adjusted OR: 1.81; 95% CI 1.56-2.10), CoH (adjusted OR 1.48; 95% CI 1.44-1.1.52), and LoS (adjusted OR 1.40; 95% CI 1.37-1.43) compared to >65y GMP with muscle loss phenotype.

Conclusion: Muscle loss phenotype is more commonly associated with increasing age in hospitalized patients with HF. Clinical outcomes were significantly worse in patients with HF aged >65y compared to younger patients with HF and all age strata in GMP with and without a muscle loss phenotype.

Keywords: aging; clinical outcomes; heart failure; inpatient mortality; sarcopenia.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest –

The other authors have no financial conflicts of interest. Personal – The authors have no personal conflicts of interest. Potential Conflicts- the authors have no other potential conflicts of interest.

Figures

Figure 1.
Figure 1.
Race and ethnicity proportions among a random 2% inpatient sample of the general medicine population (GMP) and inpatient heart failure patients with muscle loss phenotype from the National Inpatient Sample database stratified by age group.
Figure 2.
Figure 2.
Graphical abstract of the risk factors for sarcopenia and associated outcomes in older patients with heart failure
See this image and copyright information in PMC

Comment in

References

    1. Ortman JM VV, Hogan H,. An Aging Nation: The Older Population in the United States, Current Population Reports. US Census Bureau. 2014.
    1. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8: 30–41. - PMC - PubMed
    1. Bosch L, Assmann P, de Grauw WJC, Schalk BWM, Biermans MCJ. Heart failure in primary care: prevalence related to age and comorbidity. Prim Health Care Res Dev. 2019;20: e79–e79. - PMC - PubMed
    1. Antunes AC, Araujo DA, Verissimo MT, Amaral TF. Sarcopenia and hospitalisation costs in older adults: a cross-sectional study. Nutr Diet. 2017;74: 46–50. - PubMed
    1. Hazra NC, Rudisill C, Gulliford MC. Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or proximity to death? Eur J Health Econ. 2018;19: 831–842. - PMC - PubMed

Publication types

MeSH terms